Stablecoin Development Corp. (SDEV)
1.54
-0.45
(-22.61%)
USD |
NYAM |
Oct 09, 16:00
1.54
0.00 (0.00%)
After-Hours: 20:00
Stablecoin Development EPS Diluted (Quarterly) : -1.323 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.323 |
| March 31, 2026 | 3.334 |
| September 30, 2025 | -1.100 |
| June 30, 2025 | -1.651 |
| March 31, 2025 | 1.416 |
| December 31, 2024 | -1.241 |
| September 30, 2024 | -9.597 |
| June 30, 2024 | -6.861 |
| March 31, 2024 | -149.75 |
| December 31, 2023 | -138.28 |
| September 30, 2023 | -50.48 |
| June 30, 2023 | -94.94 |
| March 31, 2023 | -115.66 |
| December 31, 2022 | -151.72 |
| September 30, 2022 | -2.964 |
| June 30, 2022 | -250.21 |
| March 31, 2022 | -13.60 |
| December 31, 2021 | -120.78 |
| September 30, 2021 | -312.13 |
| June 30, 2021 | -53.51 |
| March 31, 2021 | -44.50 |
| December 31, 2020 | -51.44 |
| September 30, 2020 | -99.05 |
| June 30, 2020 | -180.70 |
| March 31, 2020 | -69.26 |
| Date | Value |
|---|---|
| December 31, 2019 | -154.56 |
| September 30, 2019 | -18.84 |
| June 30, 2019 | -166.51 |
| March 31, 2019 | -300.21 |
| December 31, 2018 | -90.90 |
| September 30, 2018 | -128.94 |
| June 30, 2018 | -147.28 |
| March 31, 2018 | -173.72 |
| December 31, 2017 | 60.65 |
| September 30, 2017 | -196.00 |
| June 30, 2017 | -134.75 |
| March 31, 2017 | -318.50 |
| December 31, 2016 | -134.75 |
| September 30, 2016 | -416.50 |
| June 30, 2016 | -441.00 |
| March 31, 2016 | -1519.00 |
| December 31, 2015 | -1543.50 |
| September 30, 2015 | -2143.75 |
| June 30, 2015 | -2143.75 |
| March 31, 2015 | -2756.25 |
| December 31, 2014 | -2756.25 |
| September 30, 2014 | -2450.00 |
| June 30, 2014 | -1837.50 |
| March 31, 2014 | -2450.00 |
| December 31, 2013 | -3062.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.07M |
| Revenue (Quarterly) | 2.206M |
| Total Expenses (Quarterly) | 43.28M |
| Enterprise Value | 70.79M |
| Profit Margin (Quarterly) | -1.86K% |
| Earnings Yield | -48.09% |
| Normalized Earnings Yield | -137.18 |